Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when COMPASS Pathways plc publishes a filing, an earnings call transcript or a press release.

Get CMPS alerts

About Teri Loxam

Teri Loxam is recorded as CFO at COMPASS Pathways plc (CMPS). The newest filing on record that lists Teri Loxam as CFO at COMPASS Pathways plc (CMPS) is dated April 15, 2026. COMPASS Pathways plc reported in an 8-K filed December 7, 2023 that Teri Loxam was appointed Chief Financial Officer (CFO), effective March 1, 2024. Teri Loxam has spoken on 4 earnings calls across 1 company, most recently for COMPASS Pathways plc on October 31, 2024. COMPASS Pathways plc is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at COMPASS Pathways plc includes Kabir Nath (CEO and Board Member), David Norton (Chairman and Board Member), George Goldsmith (Chairman) and 7 others.

“Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Teri Loxam as Chief Financial Officer (CFO), effective the beginning of March 2024.”
COMPASS Pathways plc Form 8-K, filed December 7, 2023 · Read the filing

Teri Loxam on recent calls

“As we mentioned, we have $207 million in cash as of the end of the third quarter, which will last us at least until 2026. We announced a restructuring due to the delays, as the longer trials increase costs, and the anticipated savings from the restructuring are intended to offset that and help preserve cash.”
CFO, COMPASS Pathways plc Q3 FY2024 Earnings Call ·
“I'll now step through the Q2 financial results. Cash used in operations in the second quarter was $34.4 million, within the guidance range we provided of $32 million to $38 million.”
CFO, COMPASS Pathways plc Q2 FY2024 Earnings Call ·
“I'll now step through the Q1 financial results. Cash used in operations in the first quarter was $20.8 million, within the guidance range we provided of $17 million to $23 million and which assumes that 2022 R&D tax credit would be received in the first quarter.”
CFO, COMPASS Pathways plc Q1 FY2024 Earnings Call ·
“Now that I'm back at sea level, I'm really happy to be joining you in this experience and pioneering leadership team. Similar to many, I sadly witnessed the impact of mental health issues on people close to me.”
CFO, COMPASS Pathways plc Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at COMPASS Pathways plc

Recent activity